MedPath

PHARMALINK

🇵🇭Philippines
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:1
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group

Active, not recruiting
Conditions
Non-muscle-invasive Bladder Cancer
First Posted Date
2023-05-18
Last Posted Date
2024-04-03
Lead Sponsor
Pharmalink
Target Recruit Count
600
Registration Number
NCT05864599
Locations
🇪🇸

Hospital Vithas 9 d'Octubre, Valencia, Spain

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.